GlassScriptPhysician profile
Daniel Collin Dorsey
NPI 1285697128
$777.21
in general payments reported to CMS, 2019-2025
16 companies · $46.71 in 2025
The $46.71 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $118 · 2021: $113 · 2022: $49.37 · 2023: $95.91 · 2024: $39.46 · 2025: $46.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $138.80 | 2019 | |
| Dexcom, INC. | $100.61 | 2021-2023 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $69.89 | 2019-2022 | |
| Abbvie INC. | $67.10 | 2021-2023 | Synthroid |
| Sanofi-Aventis U.S. LLC | $65.50 | 2019-2023 | |
| Novo Nordisk INC | $64.42 | 2020-2024 | Rybelsus, Ozempic |
| Abbott Laboratories | $58.07 | 2019-2024 | Freestyle Libre 3 |
| Amgen INC. | $51.30 | 2019 | |
| Ascendis Pharma Endocrinology INC | $29.27 | 2025 | Yorvipath |
| Senseonics, Incorporated | $23.00 | 2019 | |
| Tandem Diabetes Care, INC. | $21.46 | 2020 | |
| Medtronic Minimed, INC. | $21.15 | 2019 | |
| Insulet Corporation | $18.92 | 2021 | |
| Radius Health, INC. | $17.83 | 2021 | |
| Chiesi USA, INC. | $17.44 | 2025 | Mycapssa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Dorsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.